Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

QNRXQNRX
5 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in QUOIN PHARMACEUTICALS LTD

Yes. RhumbLine Advisers holds 2,332 shares of QNRX (Quoin Pharmaceuticals), worth $11,280, as of its Q2 2026 13F filing. It increased the position by 811 shares (+53.3%) from Q1 2026. RhumbLine Advisers has held QNRX since Q2 2025, across 5 quarterly 13F filings.

Current Value

$11,280

Current Shares

2,332

Total Value Change

-$168

Total Shares Change

+1,090

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2,332
+53.3%
$11,2800.0%$4.84
17
2026-Q1
Decreased
1,521
-8.7%
$10,0330.0%$6.60
0
2025-Q4
Increased
1,666
+37.7%
$24,0310.0%$14.43
17
2025-Q3
Decreased
1,210
-2.6%
$8,6960.0%$7.19
0
2025-Q2
New
1,242
-
$11,4480.0%$9.23
27

Other major holders of QNRX: Woodline Partners LP, Aberdeen Group plc, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used